Antidepressive Agents - Therapeutic use
Research News and Information

Saturday, November 21, 2009

Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.

30 Oct 2009 CONTEXT: Previous studies have found that few chronically depressed patients remit with antidepressant medications alone. OBJECTIVE: To determine the role of adjunctive psychotherapy in the treatment of chronically depressed patients with less than ... Read more...

Bipolar II postpartum depression: Detection, diagnosis, and treatment.

30 Oct 2009 Research on postpartum mood disorders has focused primarily on major depressive disorder, bipolar I disorder, and puerperal psychosis and has largely ignored or neglected bipolar II disorder. Hypomanic symptoms are common after delivery but ... Read more...

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

19 Oct 2009 CONTEXT: Studies of depressed psychiatric patients have shown that antidepressant efficacy can be increased by augmentation with omega-3 fatty acids. OBJECTIVE: To determine whether omega-3 improves the response to sertraline in patients with major ... Read more...

Latest indexed articles for 'Antidepressive Agents - Therapeutic use'

These are the very latest articles for this heading:

• Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. 30 Oct 2009
• Bipolar II postpartum depression: Detection, diagnosis, and treatment. 30 Oct 2009
• Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. 19 Oct 2009
• Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. 13 Oct 2009
• Treating premenstrual dysphoric disorder. Options include drugs targeting serotonin and various types of hormone therapy. 29 Sep 2009
• Incremental benefit and cost of telephone care management and telephone psychotherapy for depression in primary care. 29 Sep 2009
• Antidepressant use and preterm birth. 29 Sep 2009
• Rapid improvement in affective information processing after acute administration of reboxetine. 29 Sep 2009
• Treatment of neuropathic pain: an overview of recent guidelines. 29 Sep 2009
• Effect of acute antidepressant administration on negative affective bias in depressed patients. 13 Sep 2009
• Progress on primary care management of depression. 13 Sep 2009
• Case management for depression by health care assistants in small primary care practices: a cluster randomized trial. 13 Sep 2009
• [Mood disorders in patients with chronic kidney disease. Diagnosis, screening and treatment of depression] 11 Sep 2009
• A 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathy. 6 Sep 2009
• [Diagnosis and therapy of depression in family practice] 4 Sep 2009
• Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Sep 2009
• Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review. 30 Aug 2009
• Effective use of electroconvulsive therapy after craniofacial reconstructive surgery. 30 Aug 2009
• Emerging drugs for major depressive disorder. 30 Aug 2009
• Meta-analytic interval estimation for standardized and unstandardized mean differences. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Antidepressive Agents'

Definition: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

Registry Number: 0

Descriptor UI: D000928

Alternative terms: Antidepressive Agents; Agents, Antidepressive; Antidepressant Drugs; Drugs, Antidepressant; Antidepressants; Thymoleptics; Thymoanaleptics;

Related Mesh Headings: Monoamine Oxidase Inhibitors;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.427.700.122;

Online Note: use ANTIDEPRESSIVE AGENTS to search PSYCHIC ENERGIZERS 1966-94; use ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS to search THYMOLEPTICS 1969-78

History Note: 66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78

Technical Notes: GEN or unspecified; prefer specific groups or specific antidepressive agents; consider also DEPRESSION /drug ther